vimarsana.com
  1. Home
  2. Live Updates
  3. Nonclinical Development Translational Science At Sciwind - Breaking News

Latest Breaking News On - Nonclinical development translational science at sciwind - Page 1 : vimarsana.com

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW014, an oral small molecule GLP-1 receptor agonist for the Treatment of Obesity and Type 2 Diabetes

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat.

Martijn fenauxNonclinical development translational science at sciwindPrnewswire sciwind biosciences co ltdNonclinical developmentTranslational scienceHangzhou sciwind biosciences co

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.